Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
X4 Pharmaceuticals
Biotech
Mirati CEO exits—Chutes & Ladders
Mirati CEO Meek steps down. Two more Illumina execs depart. Foghorn to switch up CMO.
Max Bayer
,
Gabrielle Masson
Aug 11, 2023 9:30am
X4 scores a phase 3 win for immune deficiency disorder drug
Nov 30, 2022 10:45am
Rubius execs depart as the walls close in—Chutes & Ladders
Nov 4, 2022 9:30am
X4 joins handful of biotechs sending staff out the door
Jul 21, 2022 10:55am
Novartis alums unveil their next act—Chutes & Ladders
Nov 6, 2020 9:30am
Alexion bids adieu to CFO in possible M&A pivot—Chutes & Ladders
Sep 20, 2019 9:30am